Suresh Balu

Suresh Balu serves as the Executive Director of the Duke Institute for Health Innovation and the Associate Dean for Innovation & Partnerships at the Duke University School of Medicine. With a distinguished career in clinical research and healthcare innovation, he is a renowned expert in strategizing and implementing advanced solutions in the health sector. His tenure as the strategy leader at the Duke Clinical Research Institute showcases his profound understanding and expertise in clinical research development. Additionally, Suresh’s significant contributions to PCORnet’s strategy further exemplify his exceptional leadership in the field of clinical research. He is also recognized for his advisory role to Dr. Robert Califf, the current FDA Commissioner. Among his most notable achievements is his pioneering work in artificial intelligence, particularly in the creation, validation, and deployment of AI technologies in healthcare. Suresh’s vision and expertise have been instrumental in driving forward the integration of AI in medical practices, earning him widespread acclaim in the field of health innovation.